Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
176.2 USD | +0.69% | 0.00% | -33.19% |
10/07 | Markets Powered by Alternating Current | |
09/07 | Mixed feelings |
Chart calendar Sartorius Stedim Biotech
Upcoming events on Sartorius Stedim Biotech
Past events on Sartorius Stedim Biotech
30/05/2024 | Kepler Cheuvreux Digital ESG Conference |
16/05/2024 01:30 pm | Capital Markets Day |
18/04/2024 04:30 pm | Q1 2024 Earnings Call |
18/04/2024 10:32 am | Q1 2024 Earnings Release |
02/04/2024 | Détachement de for final dividend |
26/03/2024 04:30 pm | Annual General Meeting |
26/01/2024 05:30 pm | Q4 2023 Earnings Call |
26/01/2024 11:30 am | Q4 2023 Earnings Release |
19/10/2023 04:00 pm | Q3 2023 Earnings Call |
19/10/2023 10:30 am | Q3 2023 Earnings Release |
08/09/2023 | Wells Fargo Healthcare Conference |
05/09/2023 | Commerzbank & ODDO BHF Corporate Conference |
21/07/2023 07:00 pm | Q2 2023 Earnings Call |
21/07/2023 10:30 am | Q2 2023 Earnings Release |
21/06/2023 | Deutsche Bank dbAccess Conference |
01/06/2023 | Kepler Cheuvreux ESG Virtual Conference |
25/05/2023 | Gilbert Dupont Midcaps Forum |
11/05/2023 | Redburn Toronto Conference |
09/05/2023 | Bank of America Healthcare Conference |
20/04/2023 07:00 pm | Q1 2023 Earnings Call |
Past dividends on Sartorius Stedim Biotech
02/04/2024 | Annual 0.69 EUR |
30/03/2023 | Annual 1.44 EUR |
31/03/2022 | Annual 1.26 EUR |
29/03/2021 | Annual 0.68 EUR |
29/06/2020 | Annual 0.34 EUR |
29/03/2019 | Annual 0.57 EUR |
09/04/2018 | Annual 0.46 EUR |
07/04/2017 | Annual 0.42 EUR |
13/04/2016 | Annual 2 EUR |
10/04/2015 | 1.3 EUR |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 1 441 1 435 0.39% | 1 910 1 910 -0.02% | 2 887 2 877 0.35% | 3 493 3 500 -0.21% | 2 776 2 789 -0.48% | 2 896 |
EBITDA Million EUR | Released Forecast Spread | 422 423 -0.29% | 605 589 2.63% | 1 033 1 039 -0.55% | 1 221 1 212 0.75% | 785 773 1.56% | 872 |
EBIT Million EUR | Released Forecast Spread | 332 355 -6.54% | 472 485 -2.77% | 865 879 -1.5% | 1 040 1 057 -1.66% | 548 597 -8.19% | 626 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 318 343 -7.51% | 483 460 4.9% | 647 847 -23.67% | 1 130 1 158 -2.36% | 401 503 -20.21% | 471 |
Net income Million EUR | Released Forecast Spread | 235 252 -6.99% | 358 341 4.99% | 414 595 -30.37% | 876 858 2.15% | 310 341 -9.24% | 302 |
EPS EUR | Released Forecast Spread | 2,54 2,74 -7.34% | 3,88 3,67 5.6% | 4,50 6,38 -29.49% | 9,51 9,20 3.4% | 3,36 3,73 -9.95% | 3,32 |
Announcement Date | 28/01/20 | 18/02/21 | 27/01/22 | 26/01/23 | 26/01/24 | - |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S2 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 1 352 668 102.53% | 779 765 1.85% | 863 791 9.06% | 862 861 0.1% | 878 944 -6.95% | 890 906 -1.74% | 726 851 -14.65% | 676 756 -10.59% | 667 693 -3.79% | 707 679 4.07% | 667 700 -4.73% | 705 | 1 383 | 730 | 787 | |||
EBITDA Million EUR | Released Forecast Spread | 487 246 98.53% | 268 265 0.98% | 304 280 8.64% | 303 311 -2.57% | 305 320 -4.73% | 310 307 0.73% | 220 293 -24.96% | 196 226 -13.53% | 178 209 -14.7% | 191 185 3.69% | 191 196 -2.43% | 196 | 387 | 221 | 238 | |||
EBIT Million EUR | Released Forecast Spread | 165 188 -12.51% | 265 276 -3.84% | 221 230 -3.68% | 451 431 4.83% | 263 245 7.56% | 261 280 -7.08% | 263 289 -9.19% | 253 267 -5.22% | 172 266 -35.48% | 145 176 -17.36% | 76,9 171 -54.95% | 154 150 2.95% | 121 156 -22.74% | 162 | 180 | 197 | ||
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 63,8 221 -71.1% | 338 210 61.21% | 283 258 9.9% | 274 268 2.03% | 236 289 -18.26% | 149 262 -43.35% | 159 170 -6.35% | 35,5 175 -79.68% | 58,1 105 -44.75% | 77,0 122 -36.93% | 135 | 153 | 171 | |||||
Net income Million EUR | Released Forecast Spread | 8,21 159 -94.84% | 270 164 64.81% | 215 197 9.03% | 205 195 4.71% | 187 211 -11.61% | 111 194 -42.76% | 133 127 4.59% | 25,7 131 -80.39% | 39,8 63,5 -37.28% | 56,1 74,4 -24.64% | 74,6 | 87,8 | 107 | |||||
EPS EUR | Released Forecast Spread | 0,09 1,72 -94.78% | 2,93 1,77 65.16% | 2,33 2,14 9.02% | 2,22 2,12 4.76% | 2,03 2,30 -11.76% | 1,21 1,97 -38.67% | 1,44 1,31 9.89% | 0,28 1,42 -80.3% | 0,43 0,69 -37.67% | 0,58 0,78 -25.5% | 0,77 | 0,90 | 1,10 | |||||
Announcement Date | 28/01/20 | 18/02/21 | 21/07/21 | 27/01/22 | 27/01/22 | 21/04/22 | 21/07/22 | 19/10/22 | 26/01/23 | 20/04/23 | 21/07/23 | 19/10/23 | 26/01/24 | 18/04/24 | - | - | - | - |
Today 05:00 pm | ABBOTT LABORATORIES: Q2 2024 Earnings Release |
19/07/2024 10:30 am | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
25/07/2024 01:30 am | ALIGN TECHNOLOGY, INC.: Q2 2024 Earnings Release |
25/07/2024 | TELEFLEX INCORPORATED: Q2 2024 Earnings Release (Projected) |
25/07/2024 | WEST PHARMACEUTICAL SERVICES, INC.: Q2 2024 Earnings Release |
26/07/2024 01:33 am | DEXCOM, INC.: Q2 2024 Earnings Release |
26/07/2024 | AVANTOR, INC.: Q2 2024 Earnings Release |
26/07/2024 10:30 am | MEDACTA GROUP SA: Q2 2024 Sales and Revenue Release |
29/07/2024 | PARAMOUNT BED HOLDINGS CO., LTD.: Q1 2024 Earnings Release |
29/07/2024 03:30 pm | INTEGRA LIFESCIENCES HOLDINGS CORPORATION: Q2 2024 Earnings Release |
Past sector events for Sartorius Stedim Biotech
Today | MEDMIX AG: Q2 2024 Earnings Release |
12/07/2024 11:00 am | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
12/07/2024 10:30 am | ARJO AB: Q2 2024 Earnings Release |
11/07/2024 10:30 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
05/07/2024 | MANI, INC.: Q3 2024 Earnings Release |
27/06/2024 10:30 am | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
18/06/2024 04:30 pm | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release |
07/06/2024 12:44 pm | TAIDOC TECHNOLOGY CORPORATION: May 2024 Sales and Revenue Release |
05/06/2024 03:30 pm | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
28/05/2024 02:00 am | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DIM Stock
- SDMHF Stock
- Calendar Sartorius Stedim Biotech